CCL2 and COVID-19: High plasma levels of pro-inflammatory cytokines (interleukin-2, interleukin-7, granulocyte colony-stimulating factor, IP10, MCP1, MIP1A and tumor necrosis factor-α) have been observed in critically ill COVID-19 patients admitted to intensive care units.